An EASP professor will be part of the WHO’s International Agency for Research on Cancer

An EASP professor will be part of the WHO’s International Agency for Research on Cancer
An EASP professor will be part of the WHO’s International Agency for Research on Cancer

Granada/The director of the International Agency for Research on Cancer (its acronym in English IARC), Elisabete Weiderpass, has notified the election of Maria Jose Sanchezprofessor of the Andalusian School of Public Health (EASP), based in Granada, and scientific director of the Biosanitary Research Institute of Granada (ibs.GRANADA), as a new member of its Scientific Council for the next four years.

IARC is an agency of the World Health Organization (WHO) specializing in promoting international collaboration in cancer research. The Agency brings together the knowledge and tools of epidemiology, laboratory sciences and biostatistics to help identify the causes of cancer so that preventative measures can be taken and reduce the burden of disease and associated suffering.

The Scientific Council is made up of highly qualified scientists in cancer research and related fields. The Scientific Council, which meets in regular session once a year, in late January or early February, reviews the Agency’s scientific activities and makes recommendations on its continuing programme of activities and priorities.

EASP actively collaborates with IARC through the Granada Cancer Registry, directed by Professor María José Sánchez, and the European Prospective Study on Nutrition and Cancer (EPIC), a cohort study of more than 500,000 participants, including 8,000 people from Granada with a follow-up of more than 30 years. Dr. Sánchez is the principal investigator of this project in Granada, also coordinates the EPIC-Spain project and is a member of the EPIC-Europe steering committee.

Research and Cancer: The Mission of a Lifetime

Dr. Sánchez has extensive experience in the design and development of epidemiological studies related to the etiology, healthcare, inequalities and survival of patients with cancer, having led and/or Collaborated in more than 30 research projects at European, national and regional levelThe results of these projects have been reflected in more than 150 scientific publications in the last 5 years.

She is the principal investigator of a research group of excellence of the CIBER of Epidemiology and Public Health (CIBERESP), of the ibs.GRANADA and of the PAIDI Research Group of the EASP on Public Health and Health Services ResearchShe was president of the Spanish Network of Cancer Registries (REDECAN) and elected member of the Steering Committee of the European Network of Cancer Registries (ENCR). Since December 2017, she has been coordinator of the Epidemiology and Control of Chronic Diseases Programme of CIBERESP.

She is the coordinator of the EPIC-Spain study and Principal Investigator of the EPIC-Granada study. She participates in the Andalusian Cancer Strategy, coordinating the strategic line on Epidemiology and Information Systems. She is also the principal investigator of Andalusia in the Predictive Medicine Program of the IMPaCT infrastructure of the Carlos III Health Institute, which aims to recruit a multi-centre and multi-purpose cohort in Spain of 200,000 people.

In 2018 she was included in the list of highly cited researchers, being one of the world’s most cited researchers in the field of OncologyShe has been a professor in the Clinical Medicine and Public Health PhD program at the University of Granada since 2019 and has been recognized as a Visiting Scholar of the Department of Preventive Medicine and Public Health at the UGR from 2019 to 2021.

She is a member of the advisory committee of the Personalized Precision Medicine Plan of Andalusia, director of the 5P Precision Medicine Chair with the University of Granada and Roche Farma and director of the Obesity and other Metabolic Diseases Chair with the University of Granada and Novo Nordisk.

He is a member of the advisory committee of the Strategic Biobank Plan of the Public Health System of Andalusia and a member of the external scientific advisory committee of the Pfizer-University of Granada-Junta de Andalucía Center for Genomics and Oncology Research (GENYO), as well as the Health Research Institute of Castilla la Mancha (IDISCAM).

Recognitions as a researcher

Among other recognitions, Dr. Sánchez occupies the first position among Andalusian researchers and the tenth among Spanish and foreign researchers in Spain, in the second edition of the ranking prepared by the Higher Council for Scientific Research (CSIC) within its commitment to gender equality policies.

In 2019, he received the award for the best scientific career from the Science and Innovation Board and the University of Granada.

In 2023 he received the Gold Medal of the province of Granada and that of the city of Granadafor her scientific and academic research career, and was also recognized as one of the Top 10 leading women in the category of Academics, Researchers and Thinkers, awarded by the newspaper The Spanish.

For Latest Updates Follow us on Google News


PREV Sergio Bermejo returns to Zaragoza after breaking the agreement with Sporting de…
NEXT The Ibex 35 rebounds by 0.39% in the mid-session with BBVA and Sabadell in the lead